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therapy are relevant to the study but, unfortunately, were pub-
lished after the study period.
We hope that Dr Schouten and colleagues may be able to add
to our understanding by using the Revised Cardiac Risk Index and
the presence or absence of cardioprotective medication as criteria
in a similar study.
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Regarding “A prospective study of subclinical
myocardial damage in endovascular versus open repair
of infrarenal abdominal aortic aneurysms”
We read with interest the article by Abraham et al (J Vasc Surg
2005;41:377-81) reporting increased levels of cardiac troponin (cTn)
T in 9% of patients after elective endovascular repair and 25% of
patients after elective open repair of infrarenal abdominal aortic aneu-
rysm. These findings are similar to our own, in which increased levels
of cTnI were detected in 10 (29%) of 35 patients after elective open
aortic reconstruction.1 Because our study was performed in a unit that
did not perform endovascular abdominal aortic aneurysm repair at the
time, it seems unlikely that the authors’ suggestion that institutional
unfamiliarity with open aortic surgery, or more advanced arterial
disease in patients unsuitable for endovascular repair, can adequately
explain the higher incidence of myocardial injury in the open repair
group. One possible explanation for the findings may be related to the
fact that there was a higher incidence of previous myocardial infarction
in patients treated by endovascular repair (41%) compared with open
repair (22%). There is considerable evidence to support the use of
antiplatelet agents, -blockade, and statin therapy in reducing the
incidence of early and late myocardial infarction and cardiovascular
deaths in patients undergoing major vascular surgery.2-5 One would
expect a cardiologist to have been involved in the management of
myocardial infarction in these patients and, therefore, best medical
therapy to have been commenced. It is possible that such medical
optimization may have contributed to the reduction in myocardial
injury associated with endovascular repair. We would be most inter-
ested to know whether the authors have information on the relative
use of best medical therapy in their two groups of patients.
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Reply
We thank the readers for their comments, and we were very
interested to see that they have obtained a similar incidence of cTnI
elevation in 29% of patients after elective open aortic reconstruc-
tion at a unit that did not perform endovascular abdominal aortic
aneurysm repair at the time. This, in our opinion, would confirm
our results that there is a statistically and almost certainly clinically
significant difference in the incidence of subclinical myocardial
damage after the two types of infrarenal abdominal aortic aneu-
rysm repair. In our two groups of patients, the preoperative man-
agement did not include routine -blockade and statin therapy.
Although this was not prospectively documented, medical optimi-
zation was more likely to have taken place in the open group in
view of the degree of severity of the planned procedure. It is quite
unlikely that medical optimization would have contributed to the
reduction in myocardial injury associated with endovascular repair.
Our study protocol, as approved by the local ethics commit-
tee, dictated analysis of all samples in batches in a way that was not
related to the day-to-day management of the individual patient.
This was to avoid unnecessary interventions based on the results of
a serum analysis that under normal circumstances would not take
place according to the best current practice of that time, because
troponin measurement is not a routine part of postoperative pa-
tient care.
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Regarding “Ultrasound findings after radiofrequency
ablation of the great saphenous vein: Descriptive
analysis”
In the recent article by Sergio Salles-Cunha et al,1 the authors
suggest a very high neovascularization rate after radiofrequency
ablation (RF) of the great saphenous vein (GSV), which does not
correspond to our own experience. The authors describe small
vessel networks (SVN), which covers without discrimination all
vessels smaller than 2 mm in the surrounding tissue of the treated
GSV, including muscular, collateral, and tributary veins and their
satellite arteries. The high prevalence of these SVN elements in the
groin area and at the thigh level is interpreted as the result of a
process similar to the neovascularization described after GSV liga-
tion and stripping. However, without a controlled assessment of
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